Summary
Updated Aug 30, 2026
Gillian Cannon files SEC Form 4 reports at Xenon Pharmaceuticals Inc. (XENE). 5 SEC Form 4 filings on record going back to 2025, most recently on 9 June 2026. Most recent open-market trade: sold $63K of XENE on 9 June 2026. Lifetime open-market sales: $63K.
Recent Transactions
5Every recent SEC Form 4 transaction Gillian Cannon has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Gillian Cannon files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ian Mortimer - $21.30M of XENE open-market activity in the last 12 months
- Steven Gannon - $641K of XENE open-market activity in the last 12 months
- Christopher John Kenney - $244K of XENE open-market activity in the last 12 months
- Andrea Difabio - $231K of XENE open-market activity in the last 12 months
- Gary Patou - $70K of XENE open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Gillian Cannon?
Gillian Cannon is a corporate insider of Xenon Pharmaceuticals Inc. (XENE). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Gillian Cannon submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Gillian Cannon been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($63K) across all tracked filings.
Where can I see all of Gillian Cannon's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Gillian Cannon and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
